1. A manufacturer who asks the Institut national d’excellence en santé et en services sociaux to conduct a scientific evaluation of a drug, stable blood product or technology shall pay the fees set out in Schedule 1.
These fees vary according to the scientific evaluation that the Institut decides to conduct after receiving the request from the manufacturer and determining its eligibility for scientific evaluation.
861-2018O.C. 861-2018, s. 1; 770-2021O.C. 770-2021, s. 211.